Vaso Corp Stock Other OTC
Equities
US9223211049
Advanced Medical Equipment & Technology
End-of-day quote
Other stock markets
|
||
- USD | - |
Apr. 01 | Vaso Corporation Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Apr. 01 | Vaso Corporation Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 | CI |
Financials (USD)
Sales 2022 | 80.02M | Sales 2023 | 81.02M | Capitalization | 53.47M |
---|---|---|---|---|---|
Net income 2022 | 11M | Net income 2023 | 4M | EV / Sales 2022 | 0.13 x |
Net cash position 2022 | 18.52M | Net cash position 2023 | 23.26M | EV / Sales 2023 | 0.37 x |
P/E ratio 2022 |
2.41
x | P/E ratio 2023 |
11.1
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 52.4% |
Managers | Title | Age | Since |
---|---|---|---|
Jun Ma
CEO | Chief Executive Officer | 60 | 07-05-31 |
Jonathan Newton
DFI | Director of Finance/CFO | 63 | 10-08-31 |
Michael Beecher
DFI | Director of Finance/CFO | 79 | 11-09-20 |
Members of the board | Title | Age | Since |
---|---|---|---|
Peter Castle
COO | Chief Operating Officer | 55 | 10-08-18 |
Jun Ma
CEO | Chief Executive Officer | 60 | 07-05-31 |
David Lieberman
BRD | Director/Board Member | 79 | 11-02-27 |
1st Jan change | Capi. | |
---|---|---|
+7.71% | 218B | |
+6.25% | 182B | |
+10.60% | 132B | |
+26.73% | 108B | |
-0.49% | 62.51B | |
+15.42% | 52.98B | |
-1.89% | 47.59B | |
-1.91% | 39.96B | |
+11.16% | 39.22B |